Safety Results From Auris Medical AG's Clinical Development of AM-101 Presented at International Conference
5/17/2013 9:25:22 AM
More...
|
Auris Medical AG Secures $50.6 Million Series C Financing
4/16/2013 6:39:06 AM
More...
|
Auris Medical AG Completes Enrolment in TACTT1 Study With AM-101 for the Treatment of Acute Peripheral Tinnitus
2/13/2013 2:35:17 PM
More...
|
Auris Medical AG Reporting Positive Results From Phase IIb Trial With AM-111 for the Treatment of Acute Sensorineural Hearing Loss
11/13/2012 11:34:35 AM
More...
|
Auris Medical AG Completes Enrollment in First Stage of AM-101 TACTT1 Study
8/10/2012 11:36:58 AM
More...
|
Key Results from Auris Medical AG's Phase IIb Study of AM-101 in Acute Inner Ear Tinnitus Presented at International Conference
6/26/2012 11:44:00 AM
More...
|
Auris Medical AG Release: Publication Showing AM-111's Otoprotective Effect in Cochlear Ischemia
1/4/2012 2:35:59 PM
More...
|
Auris Medical AG Reporting Positive Results from Phase 2b Trial With AM-101 for the Treatment of Acute Inner Ear Tinnitus
10/17/2011 10:36:33 AM
More...
|
Auris Medical AG Release: AM-111 Protects Against Hearing Loss from Cochlear Implant Electrode Insertion Trauma
3/4/2011 9:53:39 AM
More...
|
Auris Medical AG Starting Enrolment in First US Clinical Trial with AM-101
2/28/2011 11:43:39 AM
More...
|
|